| A critical review on the use of modern sophisticated hyphenated tools in the characterization of impurities and degradation products S Singh, T Handa, M Narayanam, A Sahu, M Junwal, RP Shah Journal of pharmaceutical and biomedical analysis 69, 148-173, 2012 | 223 | 2012 |
| Critical practical aspects in the application of liquid chromatography–mass spectrometric studies for the characterization of impurities and degradation products M Narayanam, T Handa, P Sharma, S Jhajra, PK Muthe, PK Dappili, ... Journal of pharmaceutical and biomedical analysis 87, 191-217, 2014 | 96 | 2014 |
| Stress degradation studies on lornoxicam using LC, LC–MS/TOF and LC–MSn DT Modhave, T Handa, RP Shah, S Singh Journal of pharmaceutical and biomedical analysis 56 (3), 538-545, 2011 | 40 | 2011 |
| Characterization of a new degradation product of nifedipine formed on catalysis by atenolol: A typical case of alteration of degradation pathway of one drug by another T Handa, S Singh, IP Singh Journal of Pharmaceutical and Biomedical Analysis 89, 6-17, 2014 | 29 | 2014 |
| Successful characterization of degradation products of drugs using LC-MS tools: Application to piroxicam and meloxicam DT Modhave, T Handa, RP Shah, S Singh Analytical methods 3 (12), 2864-2872, 2011 | 29 | 2011 |
| ICH guidance in practice: degradation behaviour of oseltamivir phosphate under stress conditions M Junwal, A Sahu, T Handa, RP Shah, S Singh Journal of pharmaceutical and biomedical analysis 62, 48-60, 2012 | 25 | 2012 |
| Study of the forced degradation behavior of prasugrel hydrochloride by liquid chromatography with mass spectrometry and liquid chromatography with NMR detection and prediction … DK Singh, A Sahu, T Handa, M Narayanam, S Singh Journal of Separation Science 38 (17), 2995-3005, 2015 | 15 | 2015 |
| LC–MS/TOF, LC–MSn and H/D Exchange Studies on Solifenacin Succinate Targeted to Characterize its Forced Degradation Products DK Singh, M Kurmi, T Handa, S Singh Chromatographia 79, 159-168, 2016 | 14 | 2016 |
| Molecular insight into atypical instability behavior of fixed-dose combination containing amlodipine besylate and losartan potassium T Handa, S Jhajra, S Bhagat, PV Bharatam, AK Chakraborti, S Singh Journal of Pharmaceutical and Biomedical Analysis 136, 66-80, 2017 | 6 | 2017 |
| Explanation through density functional theory of the unanticipated loss of CO2 and differences in mass fragmentation profiles of ritonavir and its rCYP3A4‐mediated … S Jhajra, T Handa, S Bhatia, PV Bharatam, S Singh Journal of Mass Spectrometry 49 (6), 452-467, 2014 | | 2014 |
